 | • レポートコード：MRC2102QY8275 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の低分子量ヘパリン市場について種類別（エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン）、用途別（静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・低分子量ヘパリン市場の概要 ・世界の主要地域別低分子量ヘパリン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の低分子量ヘパリン市場規模2015-2026：種類別（エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン） ・世界の低分子量ヘパリン市場規模2015-2026：用途別（静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動、その他） ・低分子量ヘパリンの米国市場規模2015-2020 ・低分子量ヘパリンのヨーロッパ市場規模2015-2020 ・低分子量ヘパリンの中国市場規模2015-2020 ・低分子量ヘパリンの日本市場規模2015-2020 ・低分子量ヘパリンの東南アジア市場規模2015-2020 ・低分子量ヘパリンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・低分子量ヘパリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・低分子量ヘパリンの市場動向・機会・課題 ・調査の結論 |
Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.
In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second’s largest market with the share of 30.49%.
At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins.
China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price.
In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others.
Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global.
Market Analysis and Insights: Global Low Molecular Weight Heparin Market
The global Low Molecular Weight Heparin market size is projected to reach US$ 440.4 million by 2026, from US$ 321.2 million in 2020, at a CAGR of 5.4% during 2021-2026.
Global Low Molecular Weight Heparin Scope and Market Size
The global Low Molecular Weight Heparin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Low Molecular Weight Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Low Molecular Weight Heparin market is segmented into
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Segment by Application, the Low Molecular Weight Heparin market is segmented into
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
The Low Molecular Weight Heparin market is analysed and market size information is provided by regions (countries). Segment by Application, the Low Molecular Weight Heparin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Low Molecular Weight Heparin Market Share Analysis
Low Molecular Weight Heparin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Low Molecular Weight Heparin business, the date to enter into the Low Molecular Weight Heparin market, Low Molecular Weight Heparin product introduction, recent developments, etc.
The major vendors covered:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
1 Low Molecular Weight Heparin Market Overview
1.1 Low Molecular Weight Heparin Product Scope
1.2 Low Molecular Weight Heparin Segment by Type
1.2.1 Global Low Molecular Weight Heparin Sales by Type (2020-2026)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Low Molecular Weight Heparin Segment by Application
1.3.1 Global Low Molecular Weight Heparin Sales Comparison by Application (2020-2026)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Low Molecular Weight Heparin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Low Molecular Weight Heparin Sales Growth Rate (2015-2026)
1.4.2 Global Low Molecular Weight Heparin Revenue and Growth Rate (2015-2026)
1.4.3 Global Low Molecular Weight Heparin Price Trends (2015-2026)
2 Low Molecular Weight Heparin Estimate and Forecast by Region
2.1 Global Low Molecular Weight Heparin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Low Molecular Weight Heparin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Low Molecular Weight Heparin Sales Market Share by Region (2015-2020)
2.2.2 Global Low Molecular Weight Heparin Revenue Market Share by Region (2015-2020)
2.3 Global Low Molecular Weight Heparin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Low Molecular Weight Heparin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Low Molecular Weight Heparin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.2 Europe Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.3 China Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.4 Japan Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Low Molecular Weight Heparin Estimates and Projections (2015-2026)
2.4.6 India Low Molecular Weight Heparin Estimates and Projections (2015-2026)
3 Global Low Molecular Weight Heparin Competition Landscape by Players
3.1 Global Top Low Molecular Weight Heparin Players by Sales (2015-2020)
3.2 Global Top Low Molecular Weight Heparin Players by Revenue (2015-2020)
3.3 Global Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Low Molecular Weight Heparin as of 2019)
3.4 Global Low Molecular Weight Heparin Average Price by Company (2015-2020)
3.5 Manufacturers Low Molecular Weight Heparin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Low Molecular Weight Heparin Players (Opinion Leaders)
4 Global Low Molecular Weight Heparin Market Size by Type
4.1 Global Low Molecular Weight Heparin Historic Market Review by Type (2015-2020)
4.1.1 Global Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
4.1.2 Global Low Molecular Weight Heparin Revenue Market Share by Type (2015-2020)
4.1.3 Global Low Molecular Weight Heparin Price by Type (2015-2020)
4.2 Global Low Molecular Weight Heparin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Low Molecular Weight Heparin Sales Forecast by Type (2021-2026)
4.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Type (2021-2026)
4.2.3 Global Low Molecular Weight Heparin Price Forecast by Type (2021-2026)
5 Global Low Molecular Weight Heparin Market Size by Application
5.1 Global Low Molecular Weight Heparin Historic Market Review by Application (2015-2020)
5.1.1 Global Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
5.1.2 Global Low Molecular Weight Heparin Revenue Market Share by Application (2015-2020)
5.1.3 Global Low Molecular Weight Heparin Price by Application (2015-2020)
5.2 Global Low Molecular Weight Heparin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Low Molecular Weight Heparin Sales Forecast by Application (2021-2026)
5.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Application (2021-2026)
5.2.3 Global Low Molecular Weight Heparin Price Forecast by Application (2021-2026)
6 United States Low Molecular Weight Heparin Market Facts & Figures
6.1 United States Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
6.2 United States Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
6.3 United States Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
7 Europe Low Molecular Weight Heparin Market Facts & Figures
7.1 Europe Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
7.2 Europe Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
7.3 Europe Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
8 China Low Molecular Weight Heparin Market Facts & Figures
8.1 China Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
8.2 China Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
8.3 China Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
9 Japan Low Molecular Weight Heparin Market Facts & Figures
9.1 Japan Low Molecular Weight Heparin Sales Market Share by Company (3015-3030)
9.2 Japan Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
9.3 Japan Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
10 Southeast Asia Low Molecular Weight Heparin Market Facts & Figures
10.1 Southeast Asia Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
11 India Low Molecular Weight Heparin Market Facts & Figures
11.1 India Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
11.2 India Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
11.3 India Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Low Molecular Weight Heparin Business
12.1 Aspen
12.1.1 Aspen Corporation Information
12.1.2 Aspen Business Overview
12.1.3 Aspen Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Aspen Low Molecular Weight Heparin Products Offered
12.1.5 Aspen Recent Development
12.2 Sanofi-aventis
12.2.1 Sanofi-aventis Corporation Information
12.2.2 Sanofi-aventis Business Overview
12.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi-aventis Low Molecular Weight Heparin Products Offered
12.2.5 Sanofi-aventis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Low Molecular Weight Heparin Products Offered
12.3.5 Pfizer Recent Development
12.4 Opocrin
12.4.1 Opocrin Corporation Information
12.4.2 Opocrin Business Overview
12.4.3 Opocrin Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Opocrin Low Molecular Weight Heparin Products Offered
12.4.5 Opocrin Recent Development
12.5 CSBIO
12.5.1 CSBIO Corporation Information
12.5.2 CSBIO Business Overview
12.5.3 CSBIO Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CSBIO Low Molecular Weight Heparin Products Offered
12.5.5 CSBIO Recent Development
12.6 Dongying Tiandong Pharmaceutical
12.6.1 Dongying Tiandong Pharmaceutical Corporation Information
12.6.2 Dongying Tiandong Pharmaceutical Business Overview
12.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Products Offered
12.6.5 Dongying Tiandong Pharmaceutical Recent Development
12.7 Changzhou Qianhong Bio-pharma
12.7.1 Changzhou Qianhong Bio-pharma Corporation Information
12.7.2 Changzhou Qianhong Bio-pharma Business Overview
12.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Products Offered
12.7.5 Changzhou Qianhong Bio-pharma Recent Development
12.8 Techdow
12.8.1 Techdow Corporation Information
12.8.2 Techdow Business Overview
12.8.3 Techdow Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Techdow Low Molecular Weight Heparin Products Offered
12.8.5 Techdow Recent Development
12.9 Yantai Dongcheng Pharmaceutical Group
12.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
12.9.2 Yantai Dongcheng Pharmaceutical Group Business Overview
12.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Products Offered
12.9.5 Yantai Dongcheng Pharmaceutical Group Recent Development
13 Low Molecular Weight Heparin Manufacturing Cost Analysis
13.1 Low Molecular Weight Heparin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Low Molecular Weight Heparin
13.4 Low Molecular Weight Heparin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Low Molecular Weight Heparin Distributors List
14.3 Low Molecular Weight Heparin Customers
15 Market Dynamics
15.1 Low Molecular Weight Heparin Market Trends
15.2 Low Molecular Weight Heparin Opportunities and Drivers
15.3 Low Molecular Weight Heparin Market Challenges
15.4 Low Molecular Weight Heparin Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Low Molecular Weight Heparin Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Low Molecular Weight Heparin Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Low Molecular Weight Heparin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Low Molecular Weight Heparin Sales (MT) by Region (2015-2020)
Table 5. Global Low Molecular Weight Heparin Sales Market Share by Region (2015-2020)
Table 6. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Low Molecular Weight Heparin Revenue Share by Region (2015-2020)
Table 8. Global Low Molecular Weight Heparin Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Low Molecular Weight Heparin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Low Molecular Weight Heparin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Low Molecular Weight Heparin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Low Molecular Weight Heparin (MT) of Key Companies (2015-2020)
Table 13. Global Low Molecular Weight Heparin Sales Share by Company (2015-2020)
Table 14. Global Low Molecular Weight Heparin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Low Molecular Weight Heparin Revenue Share by Company (2015-2020)
Table 16. Global Low Molecular Weight Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Low Molecular Weight Heparin as of 2019)
Table 17. Global Low Molecular Weight Heparin Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Low Molecular Weight Heparin Manufacturing Sites and Area Served
Table 19. Manufacturers Low Molecular Weight Heparin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Low Molecular Weight Heparin Players
Table 22. Global Low Molecular Weight Heparin Sales (MT) by Type (2015-2020)
Table 23. Global Low Molecular Weight Heparin Sales Share by Type (2015-2020)
Table 24. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Low Molecular Weight Heparin Price (MT) by Type (2015-2020)
Table 26. Global Low Molecular Weight Heparin Sales Share by Type (2021-2026)
Table 27. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Low Molecular Weight Heparin Revenue Share by Type (2021-2026)
Table 29. Global Low Molecular Weight Heparin Price (MT) by Type (2021-2026)
Table 30. Global Low Molecular Weight Heparin Sales (MT) by Application (2015-2020)
Table 31. Global Low Molecular Weight Heparin Sales Share by Application (2015-2020)
Table 32. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Low Molecular Weight Heparin Price (MT) by Application (2015-2020)
Table 34. Global Low Molecular Weight Heparin Sales (MT) by Application (2021-2026)
Table 35. Global Low Molecular Weight Heparin Sales Share by Application (2021-2026)
Table 36. Global Low Molecular Weight Heparin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Low Molecular Weight Heparin Revenue Share by Application (2021-2026)
Table 38. Global Low Molecular Weight Heparin Price (MT) by Application (2021-2026)
Table 39. United States Low Molecular Weight Heparin Sales (MT) by Company (2015-2020)
Table 40. United States Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
Table 41. United States Low Molecular Weight Heparin Sales (MT) by Type (2015-2020)
Table 42. United States Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
Table 43. United States Low Molecular Weight Heparin Sales (MT) by Application (2015-2020)
Table 44. United States Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
Table 45. Europe Low Molecular Weight Heparin Sales (MT) by Company (2015-2020)
Table 46. Europe Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
Table 47. Europe Low Molecular Weight Heparin Sales (MT) by Type (2015-2020)
Table 48. Europe Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
Table 49. Europe Low Molecular Weight Heparin Sales (MT) by Application (2015-2020)
Table 50. Europe Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
Table 51. China Low Molecular Weight Heparin Sales (MT) by Company (2015-2020)
Table 52. China Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
Table 53. China Low Molecular Weight Heparin Sales (MT) by Type (2015-2020)
Table 54. China Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
Table 55. China Low Molecular Weight Heparin Sales (MT) by Application (2015-2020)
Table 56. China Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
Table 57. Japan Low Molecular Weight Heparin Sales (MT) by Company (2015-2020)
Table 58. Japan Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
Table 59. Japan Low Molecular Weight Heparin Sales (MT) by Type (2015-2020)
Table 60. Japan Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
Table 61. Japan Low Molecular Weight Heparin Sales (MT) by Application (2015-2020)
Table 62. Japan Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Low Molecular Weight Heparin Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Low Molecular Weight Heparin Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Low Molecular Weight Heparin Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
Table 69. India Low Molecular Weight Heparin Sales (MT) by Company (2015-2020)
Table 70. India Low Molecular Weight Heparin Sales Market Share by Company (2015-2020)
Table 71. India Low Molecular Weight Heparin Sales (MT) by Type (2015-2020)
Table 72. India Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
Table 73. India Low Molecular Weight Heparin Sales (MT) by Application (2015-2020)
Table 74. India Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
Table 75. Aspen Corporation Information
Table 76. Aspen Description and Business Overview
Table 77. Aspen Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Aspen Low Molecular Weight Heparin Product
Table 79. Aspen Recent Development
Table 80. Sanofi-aventis Corporation Information
Table 81. Sanofi-aventis Description and Business Overview
Table 82. Sanofi-aventis Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sanofi-aventis Low Molecular Weight Heparin Product
Table 84. Sanofi-aventis Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Low Molecular Weight Heparin Product
Table 89. Pfizer Recent Development
Table 90. Opocrin Corporation Information
Table 91. Opocrin Description and Business Overview
Table 92. Opocrin Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Opocrin Low Molecular Weight Heparin Product
Table 94. Opocrin Recent Development
Table 95. CSBIO Corporation Information
Table 96. CSBIO Description and Business Overview
Table 97. CSBIO Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. CSBIO Low Molecular Weight Heparin Product
Table 99. CSBIO Recent Development
Table 100. Dongying Tiandong Pharmaceutical Corporation Information
Table 101. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 102. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product
Table 104. Dongying Tiandong Pharmaceutical Recent Development
Table 105. Changzhou Qianhong Bio-pharma Corporation Information
Table 106. Changzhou Qianhong Bio-pharma Description and Business Overview
Table 107. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product
Table 109. Changzhou Qianhong Bio-pharma Recent Development
Table 110. Techdow Corporation Information
Table 111. Techdow Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Techdow Description and Business Overview
Table 113. Techdow Low Molecular Weight Heparin Product
Table 114. Techdow Recent Development
Table 115. Yantai Dongcheng Pharmaceutical Group Corporation Information
Table 116. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Yantai Dongcheng Pharmaceutical Group Description and Business Overview
Table 118. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product
Table 119. Yantai Dongcheng Pharmaceutical Group Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Low Molecular Weight Heparin Distributors List
Table 123. Low Molecular Weight Heparin Customers List
Table 124. Low Molecular Weight Heparin Market Key Trends
Table 125. Low Molecular Weight Heparin Key Opportunities and Drivers
Table 126. Low Molecular Weight Heparin Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Low Molecular Weight Heparin Product Picture
Figure 2. Global Low Molecular Weight Heparin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Low Molecular Weight Heparin Market Share by Application in 2020 & 2026
Figure 6. Treatment of Venous Thromboembolism Examples
Figure 7. Complications of Pregnancy Examples
Figure 8. Cardioversion of Atrial Fibrillation/Flutter Examples
Figure 9. Others Examples
Figure 10. Global Low Molecular Weight Heparin Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Low Molecular Weight Heparin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Low Molecular Weight Heparin Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Low Molecular Weight Heparin Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Low Molecular Weight Heparin Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Low Molecular Weight Heparin Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Low Molecular Weight Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Low Molecular Weight Heparin Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Low Molecular Weight Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Low Molecular Weight Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Low Molecular Weight Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Low Molecular Weight Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Low Molecular Weight Heparin Players Market Share by Revenue in Low Molecular Weight Heparin 2015 & 2019
Figure 28. Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Low Molecular Weight Heparin Revenue Share by Type (2015-2020)
Figure 30. Global Low Molecular Weight Heparin Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Low Molecular Weight Heparin Revenue Share by Application (2015-2020)
Figure 32. Global Low Molecular Weight Heparin Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Low Molecular Weight Heparin Sales Market Share by Type in 2019
Figure 34. United States Low Molecular Weight Heparin Sales Market Share by Type in 2019
Figure 35. Europe Low Molecular Weight Heparin Sales Market Share by Company in 2019
Figure 36. Europe Low Molecular Weight Heparin Sales Market Share by Type in 2019
Figure 37. Europe Low Molecular Weight Heparin Sales Market Share by Application in 2019
Figure 38. China Low Molecular Weight Heparin Sales Market Share by Company in 2019
Figure 39. China Low Molecular Weight Heparin Sales Market Share by Type in 2019
Figure 40. China Low Molecular Weight Heparin Sales Market Share by Application in 2019
Figure 41. Japan Low Molecular Weight Heparin Sales Market Share by Company in 2019
Figure 42. Japan Low Molecular Weight Heparin Sales Market Share by Type in 2019
Figure 43. Japan Low Molecular Weight Heparin Sales Market Share by Application in 2019
Figure 44. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Company in 2019
Figure 45. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Type in 2019
Figure 46. Southeast Asia Low Molecular Weight Heparin Sales Market Share by Application in 2019
Figure 47. India Low Molecular Weight Heparin Sales Market Share by Company in 2019
Figure 48. India Low Molecular Weight Heparin Sales Market Share by Type in 2019
Figure 49. India Low Molecular Weight Heparin Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Low Molecular Weight Heparin
Figure 52. Manufacturing Process Analysis of Low Molecular Weight Heparin
Figure 53. Low Molecular Weight Heparin Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
医療用超高分子量ポリエチレン（UHMWPE）の世界市場レポート2020 Medical ultra high molecular weight polyethylene (UHMWPE or UHMW), is a kind of thermoplastic polyethylene chemical materials, which has high molecular weight over 1.5millon as usual. Medical ultra high molecular weight polyethylene offers a unique combination of wear and corrosion resistance, low f…- 中分子量ポリイソブチレンの世界市場レポート2020 Medium molecular weight polyisobutylene’s average molecular weight ranges between 40,000 and 120,000 g/mol. Medium molecular weight polyisobutylene is employed as viscosity modifier, tack improver in adhesive formulations, and primary binder in caulking and sealing compounds. It is also used in fuel…
- 低分子量フルオロポリマーの世界市場レポート2020 Market Analysis and Insights: Global Low Molecular Weight Fluoropolymer Market The global Low Molecular Weight Fluoropolymer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Low Molecular Weight Fluoropolymer Scope and M…
- 超高分子量ポリエチレン（UHMWPE）の世界市場レポート2020 Ultra-high molecular weight polyethylene (UHMWPE or UHMW), is a kind of thermoplastic polyethylene chemical materials, which has high molecular weight over 1.5millon as usual. Ultra-high molecular weight polyethylene offers a unique combination of wear and corrosion resistance, low friction surface,…
- 超高分子量ポリエチレン繊維（UHMWPE）の世界市場レポート2020 Ultra-high molecular weight polyethylene (UHMWPE or UHMW), is a kind of thermoplastic polyethylene chemical materials, which has high molecular weight over 1.5millon as usual. Ultra-high molecular weight polyethylene offers a unique combination of wear and corrosion resistance, low friction surface,…